Erythromelalgia in a Patient with Mast Cell Activation Syndrome: Response to Low Dose Naltrexone
-
Published:2020-05-08
Issue:3
Volume:4
Page:288
-
ISSN:2574-1624
-
Container-title:SKIN The Journal of Cutaneous Medicine
-
language:
-
Short-container-title:J of Skin
Author:
Kurta Anastasia O,Weinstock Leonard B,Semchyshyn Natalie
Abstract
Erythromelalgia is a rare condition that may be associated with a variety of underlying conditions and can be refractory to therapy. We report a case of a patient with mast cell activation syndrome (MCAS) who developed erythromelalgia and responded to low dose naltrexone (LDN).
Publisher
National Society for Cutaneous Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献